I guess that's the flip side or another facet of R and D. We don't see any evidence of that.
I will say that clinical trial intensity is going down in developed countries across the board, as industry kind of moves their R and D efforts into emerging markets. We've seen a bit of a decline in Canada in clinical trials recently.